MARUF LAB
  • HOME
  • RESEARCH
    • PGx-SImBA
    • PGx-SUPPORT
    • POP-R
    • Psych-PE
  • TEAM
    • CELEBRATION
  • PRECISE CaRE Hub
    • PGx RESOURCES
  • PUBLICATIONS
  • OPPORTUNITIES
The PGxK2A Lab, led by Dr. Abdullah Al Maruf, advances precision medicine through clinical pharmacogenomics, psychiatric pharmacoepidemiology, and implementation science. Our research spans the translational spectrum, from discovering how genomic variation influences medication response to generating real-world evidence on medication use and health outcomes, and ultimately advancing the implementation of precision medicine in routine clinical practice.

Our mission is to generate evidence that enables safer, more effective, and more equitable medication use across diverse populations. Working collaboratively with patients, public partners, healthcare practitioners, researchers, health system leaders, and policymakers, we design and evaluate innovative approaches to implementing precision medicine in real-world settings. We are equally committed to training the next generation of researchers and healthcare professionals by fostering a collaborative, inclusive, and mentorship-driven research environment.
Research Themes: 
  • Clinical Pharmacogenomics and Precision Therapeutics: Understanding how genomic variation influences medication response, safety, and treatment outcomes to advance precision therapeutics across diverse populations.
  • Psychiatric Pharmacoepidemiology and Real-World Evidence: Using real-world clinical and population-based data to evaluate medication use, adherence, effectiveness, safety, and healthcare outcomes, generating evidence that informs precision prescribing, healthcare delivery, and health policy.
  • Implementation Science and Health System Transformation: Accelerating the integration of evidence-based precision medicine into healthcare through implementation science, knowledge mobilization, patient and health system partnerships, policy development, and workforce education.

Our lab is currently the Manitoba cohort lead or collaborator on Pan-GEM, CYMH Trials Network, KINDTrials, iBio2Div-MS, and PrairieGen, 

​Abdullah Al Maruf
B.Pharm, M.Pharm, Ph.D.

​Assistant Professor
College of Pharmacy
Rady Faculty of Health Sciences
University of Manitoba, Winnipeg, Manitoba

Scientist

Children’s Hospital Research Institute of Manitoba (CHRIM)

Adjunct Assistant Professor
Department of Psychiatry
Max Rady College of Medicine
University of Manitoba, Winnipeg, Manitoba

Adjunct Assistant Professor
Department of Psychiatry
Hotchkiss Brain Institute
Cumming School of Medicine
University of Calgary, Calgary, Alberta
Latest Lab News:
Oct: New paper out! Aziz et al. "Prescribing prevalence and trends of medications with pharmacogenetic implications: a study based on primary care data in Manitoba, Canada" in the journal Pharmacogenomics! Link
Oct: Dr. Maruf has graduated from the Teaching and Learning Certificate (TLC) program. Read UMToday Story and 2026 TLC Grad List. 
Sep: Our amazing summer student, Natalia Morcila, recently featured in a UMNews article! What happens in a dry lab? 
Aug: Our graduate students, Nuzhat Tabassum and Mahin Hasan both received Faculty of Graduate Studies Research Completion Scholarship. Congratulations! 
Read more LAB NEWS 


We are highly interested in developing collaborations to do amazing science, education, and advocacy.
​If you are interested in collaborating, please get in touch with Dr. Maruf.  


our RESEARCH PARTNERS

Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture

SUPPORT OUR RESEARCH

©2021 - 2026 MARUF Lab. All Rights Reserved.

  • HOME
  • RESEARCH
    • PGx-SImBA
    • PGx-SUPPORT
    • POP-R
    • Psych-PE
  • TEAM
    • CELEBRATION
  • PRECISE CaRE Hub
    • PGx RESOURCES
  • PUBLICATIONS
  • OPPORTUNITIES